Skip to main content
OpenTrials

Clinical trial condition

Relapsed/Refractory Acute Myeloid Leukemia (R/R-AML)

Explore clinical trials studying Relapsed/Refractory Acute Myeloid Leukemia (R/R-AML). Study availability and eligibility vary by location and protocol.

1 public trial 1 recruiting study
Refine in advanced search Browse all conditions

Relapsed/Refractory Acute Myeloid Leukemia (R/R-AML) trial results

Recruiting

Phase IIa Study to Assess Safety and Efficacy in the Relapsed/Refractory Acute Myeloid Leukemia

NCT06532058

Conditions
Disease Attributes, Hematologic Diseases, Hemic and Lymphatic Diseases, +9 more
Locations
  • Henan Cancer Hospital Zhengzhou, Henan, China
  • Zhongnan Hospital of Wuhan University Wuhan, Hubei, China
  • The First People's Hospital of Changzhou Changzhou, Jiangsu, China
  • Huai 'an First People's Hospital Huaian, Jiangsu, China
View Trial Details

Related conditions